Aktis Oncology
AKTSPublicAktis Oncology is a biotechnology company dedicated to realizing the curative power of alpha radiopharmaceuticals for the mainstream of cancer care
Market Cap
N/A
Pipeline
—
Patents
—
Publications
—
About
Aktis Oncology is a biotechnology company dedicated to realizing the curative power of alpha radiopharmaceuticals for the mainstream of cancer care
RadiopharmaceuticalsSmall Molecules
Funding History
4Total raised:$312M
Series B$84MDec 15, 2023
Series B$84MMay 15, 2023
Series A$72MOct 15, 2021
Series A$72MOct 15, 2021